Acumen Pharmaceuticals

ABOS • NASDAQ •
Overview Stats Financials News

Quarterly Financials

Values in thousands 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Revenue $0 $290 $0 $0
Gross Profit -44 251 -40 -53
EBITDA -17,774 -18,447 -16,039 -13,425
EBIT -17,818 -18,486 -16,079 -13,478
Net Income -14,873 -16,497 -12,957 -11,610
Net Change In Cash 0 290 0 0
Cost of Revenue -751
Free Cash Flow -17,870 -8,328 -12,912 -11,670
Cash 46,930 66,885 94,917 77,248
Basic Shares 59,812 57,910 54,229 41,025

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue $0 $0 $1,436 $1,436
Gross Profit -184 -169 -4 1,428
EBITDA -60,954 -45,068 61,577 -8,498
EBIT -61,138 -45,237 61,573 -7,912
Net Income -52,371 -40,475 -181,679 -7,324
Net Change In Cash 0 0 1,436 1,436
Cost of Revenue 7,939 78,385
Free Cash Flow -43,085 -35,314 -18,001 -7,450
Cash 66,885 130,101 122,162 43,777
Basic Shares 48,609 40,601 40,473 40,151

Earnings Calls

Quarter EPS
2024-03-31 -$0.25
2023-12-31 -$0.28
2023-09-30 -$0.24
2023-06-30 -$0.28